Diana Mckenzie

Insider Reports History

Reporting-owner location: New York, NY
Latest reporting-owner signature: /s/ Taylor McInerney Jansen, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Diana Mckenzie

Form 4 holding Director

VERTEX PHARMACEUTICALS INC / MA

Security class: Deferred Stock Units
Shares / value: 7,787
Estimated value: $2,413,865
Report date: 01 May 2026
Price: $402.95
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

METLIFE INC

Security class: Common Stock
Shares / value: 25,229
Estimated value: $1,784,194
Report date: 16 Jun 2026
Price: $70.72
Ownership: Direct

Form 4 holding Director

VERTEX PHARMACEUTICALS INC / MA

Security class: Common Stock
Shares / value: 2,378
Estimated value: $1,061,872
Report date: 01 May 2026
Price: $446.54
Ownership: Direct

Form 4 holding Director

VERTEX PHARMACEUTICALS INC / MA

Security class: Common Stock
Shares / value: 207
Estimated value: $92,433
Report date: 01 May 2026
Price: $446.54
Ownership: Held in Trust

Form 4 holding Director

agilon health, inc.

Security class: Common Stock
Shares / value: 7,633
Estimated value: $60,377
Report date: 02 Jun 2026
Price: $7.91
Ownership: Direct

Form 4 holding Director

Change Healthcare Inc.

Security class: Common Stock
Shares / value: 0
Estimated value
Report date: 03 Oct 2022
Price: $25.75
Ownership: Direct

Insider Reports Filed by Diana Mckenzie

4 MET

METLIFE INC

Report period: 16 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 18 Jun 2026, 16:12
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 09 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 11 Jun 2026, 16:02
Role: Director
Next action: Open filing details

4 AGL

agilon health, inc.

Report period: 02 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Jun 2026, 21:56
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 01 May 2026
Transactions: 3
Transaction value: $0
Accepted by SEC: 05 May 2026, 17:18
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 01 Apr 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Apr 2026, 16:04
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 10 Mar 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Mar 2026, 16:08
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 02 Jan 2026
Transactions: 1
Transaction value: +$51,324
Accepted by SEC: 06 Jan 2026, 16:10
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 09 Dec 2025
Transactions: 1
Transaction value: +$12,918
Accepted by SEC: 11 Dec 2025, 16:02
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 01 Oct 2025
Transactions: 1
Transaction value: +$43,751
Accepted by SEC: 03 Oct 2025, 16:02
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 09 Sep 2025
Transactions: 1
Transaction value: +$12,528
Accepted by SEC: 11 Sep 2025, 16:02
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 17 Jun 2025
Transactions: 1
Transaction value: +$43,752
Accepted by SEC: 20 Jun 2025, 16:32
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 10 Jun 2025
Transactions: 1
Transaction value: +$12,153
Accepted by SEC: 12 Jun 2025, 16:21
Role: Director
Next action: Open filing details

4 AGL

agilon health, inc.

Report period: 28 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 30 May 2025, 19:39
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 01 May 2025
Transactions: 3
Transaction value: $0
Accepted by SEC: 05 May 2025, 16:52
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 01 Apr 2025
Transactions: 1
Transaction value: +$43,826
Accepted by SEC: 03 Apr 2025, 16:27
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 11 Mar 2025
Transactions: 1
Transaction value: +$11,297
Accepted by SEC: 13 Mar 2025, 16:19
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 02 Jan 2025
Transactions: 1
Transaction value: +$43,752
Accepted by SEC: 06 Jan 2025, 16:40
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 16 Dec 2024
Transactions: 1
Transaction value: +$10,922
Accepted by SEC: 18 Dec 2024, 16:33
Role: Director
Next action: Open filing details

4 AGL

agilon health, inc.

Report period: 25 Nov 2024
Transactions: 2
Transaction value: +$44,962
Accepted by SEC: 11 Dec 2024, 17:25
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 01 Oct 2024
Transactions: 1
Transaction value: +$43,752
Accepted by SEC: 03 Oct 2024, 16:15
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 10 Sep 2024
Transactions: 1
Transaction value: +$10,523
Accepted by SEC: 12 Sep 2024, 16:32
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 18 Jun 2024
Transactions: 1
Transaction value: +$43,802
Accepted by SEC: 20 Jun 2024, 16:38
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 11 Jun 2024
Transactions: 1
Transaction value: +$10,083
Accepted by SEC: 13 Jun 2024, 16:20
Role: Director
Next action: Open filing details

4 AGL

agilon health, inc.

Report period: 29 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 31 May 2024, 20:56
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 01 May 2024
Transactions: 3
Transaction value: $0
Accepted by SEC: 03 May 2024, 16:18
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 01 Apr 2024
Transactions: 1
Transaction value: +$43,772
Accepted by SEC: 03 Apr 2024, 16:20
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Mar 2024
Transactions: 1
Transaction value: +$9,275
Accepted by SEC: 18 Mar 2024, 16:48
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 12 Jan 2024
Transactions: 1
Transaction value: +$33,125
Accepted by SEC: 17 Jan 2024, 16:05
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 02 Jan 2024
Transactions: 1
Transaction value: +$43,778
Accepted by SEC: 04 Jan 2024, 16:40
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Dec 2023
Transactions: 1
Transaction value: +$8,831
Accepted by SEC: 18 Dec 2023, 17:19
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 13 Oct 2023
Transactions: 1
Transaction value: +$33,125
Accepted by SEC: 17 Oct 2023, 16:17
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 02 Oct 2023
Transactions: 1
Transaction value: +$43,800
Accepted by SEC: 04 Oct 2023, 16:36
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Sep 2023
Transactions: 1
Transaction value: +$8,439
Accepted by SEC: 18 Sep 2023, 16:29
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 14 Jul 2023
Transactions: 1
Transaction value: +$31,545
Accepted by SEC: 18 Jul 2023, 16:14
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 20 Jun 2023
Transactions: 1
Transaction value: +$43,780
Accepted by SEC: 22 Jun 2023, 16:17
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Jun 2023
Transactions: 1
Transaction value: +$7,929
Accepted by SEC: 16 Jun 2023, 16:16
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 01 May 2023
Transactions: 3
Transaction value: $0
Accepted by SEC: 03 May 2023, 17:01
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 14 Apr 2023
Transactions: 1
Transaction value: +$30,000
Accepted by SEC: 18 Apr 2023, 17:09
Role: Director
Next action: Open filing details

4 AGL

agilon health, inc.

Report period: 14 Apr 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 18 Apr 2023, 16:48
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 03 Apr 2023
Transactions: 1
Transaction value: +$43,767
Accepted by SEC: 05 Apr 2023, 17:04
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Mar 2023
Transactions: 1
Transaction value: +$7,147
Accepted by SEC: 16 Mar 2023, 16:36
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 28 Feb 2023
Transactions: 1
Transaction value: +$2,224
Accepted by SEC: 02 Mar 2023, 18:03
Role: Director
Next action: Open filing details

4 AGL

agilon health, inc.

Report period: 17 Feb 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 22 Feb 2023, 16:20
Role: Director
Next action: Open filing details

3 AGL

agilon health, inc.

Report period: 17 Feb 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 22 Feb 2023, 16:19
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 13 Jan 2023
Transactions: 1
Transaction value: +$30,000
Accepted by SEC: 18 Jan 2023, 15:07
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 03 Jan 2023
Transactions: 1
Transaction value: +$37,518
Accepted by SEC: 05 Jan 2023, 15:27
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Dec 2022
Transactions: 1
Transaction value: +$6,847
Accepted by SEC: 16 Dec 2022, 15:25
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 14 Oct 2022
Transactions: 1
Transaction value: +$30,000
Accepted by SEC: 18 Oct 2022, 16:25
Role: Director
Next action: Open filing details

Change Healthcare Inc.

Report period: 03 Oct 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Oct 2022, 16:31
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 03 Oct 2022
Transactions: 1
Transaction value: +$37,509
Accepted by SEC: 05 Oct 2022, 16:28
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Sep 2022
Transactions: 1
Transaction value: +$6,508
Accepted by SEC: 16 Sep 2022, 16:26
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 15 Jul 2022
Transactions: 1
Transaction value: +$27,500
Accepted by SEC: 19 Jul 2022, 16:33
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 21 Jun 2022
Transactions: 1
Transaction value: +$37,518
Accepted by SEC: 23 Jun 2022, 16:14
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Jun 2022
Transactions: 1
Transaction value: +$6,186
Accepted by SEC: 16 Jun 2022, 16:29
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 01 May 2022
Transactions: 3
Transaction value: $0
Accepted by SEC: 03 May 2022, 16:48
Role: Director
Next action: Open filing details

Change Healthcare Inc.

Report period: 25 Apr 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 27 Apr 2022, 17:07
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 14 Apr 2022
Transactions: 1
Transaction value: +$27,500
Accepted by SEC: 18 Apr 2022, 16:05
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 01 Apr 2022
Transactions: 1
Transaction value: +$37,506
Accepted by SEC: 05 Apr 2022, 16:09
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Mar 2022
Transactions: 1
Transaction value: +$5,628
Accepted by SEC: 16 Mar 2022, 16:37
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 14 Jan 2022
Transactions: 1
Transaction value: +$27,500
Accepted by SEC: 19 Jan 2022, 15:21
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 03 Jan 2022
Transactions: 1
Transaction value: +$37,559
Accepted by SEC: 05 Jan 2022, 15:38
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Dec 2021
Transactions: 1
Transaction value: +$5,290
Accepted by SEC: 16 Dec 2021, 15:33
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 15 Oct 2021
Transactions: 1
Transaction value: +$27,500
Accepted by SEC: 18 Oct 2021, 16:06
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 01 Oct 2021
Transactions: 1
Transaction value: +$37,512
Accepted by SEC: 05 Oct 2021, 16:29
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Sep 2021
Transactions: 1
Transaction value: +$4,984
Accepted by SEC: 16 Sep 2021, 16:39
Role: Director
Next action: Open filing details

4 VRTX

VERTEX PHARMACEUTICALS INC / MA

Report period: 15 Jul 2021
Transactions: 1
Transaction value: +$27,500
Accepted by SEC: 16 Jul 2021, 16:06
Role: Director
Next action: Open filing details

Change Healthcare Inc.

Report period: 22 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 24 Jun 2021, 14:26
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 15 Jun 2021
Transactions: 1
Transaction value: +$37,561
Accepted by SEC: 17 Jun 2021, 17:19
Role: Director
Next action: Open filing details

4 MET

METLIFE INC

Report period: 14 Jun 2021
Transactions: 1
Transaction value: +$4,622
Accepted by SEC: 16 Jun 2021, 20:58
Role: Director
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Diana Mckenzie

Insider Reports Filed by Diana Mckenzie